Next Article in Journal
RBPvsMIR: A Computational Pipeline to Identify Competing miRNAs and RNA-Binding Protein Pairs Regulating the Shared Transcripts
Previous Article in Journal
Human Age Prediction Based on DNA Methylation Using a Gradient Boosting Regressor
Previous Article in Special Issue
What Does the Future Hold for Yellow Fever Virus? (I)

What Does the Future Hold for Yellow Fever Virus? (II)

Unité des Virus Émergents (UVE: Aix-Marseille Univ–IRD 190–Inserm 1207–IHU Méditerranée Infection), 13385 Marseille CEDEX 05, France
Charité-Universitätsmedizin Berlin, Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Institute of Virology, 10117 Berlin, Germany
German Center for Infection Research (DZIF), 38124 Braunschweig, Germany
Martsinovsky Institute of Medical Parasitology, Tropical and Vector Borne Diseases, Sechenov University, 119991 Moscow, Russia
UMR Maladies Infectieuses et Vecteurs: Écologie, Génétique Évolution et Contrôle (MIVEGEC: IRD, CNRS, Univ. Montpellier), 34394 Montpellier, France
Author to whom correspondence should be addressed.
Genes 2018, 9(9), 425;
Received: 20 June 2018 / Revised: 13 August 2018 / Accepted: 16 August 2018 / Published: 21 August 2018
(This article belongs to the Special Issue Emerging and re-Emerging Arboviruses in Human Health)
As revealed by the recent resurgence of yellow fever virus (YFV) activity in the tropical regions of Africa and South America, YFV control measures need urgent rethinking. Over the last decade, most reported outbreaks occurred in, or eventually reached, areas with low vaccination coverage but that are suitable for virus transmission, with an unprecedented risk of expansion to densely populated territories in Africa, South America and Asia. As reflected in the World Health Organization’s initiative launched in 2017, it is high time to strengthen epidemiological surveillance to monitor accurately viral dissemination, and redefine vaccination recommendation areas. Vector-control and immunisation measures need to be adapted and vaccine manufacturing must be reconciled with an increasing demand. We will have to face more yellow fever (YF) cases in the upcoming years. Hence, improving disease management through the development of efficient treatments will prove most beneficial. Undoubtedly, these developments will require in-depth descriptions of YFV biology at molecular, physiological and ecological levels. This second section of a two-part review describes the current state of knowledge and gaps regarding the molecular biology of YFV, along with an overview of the tools that can be used to manage the disease at the individual, local and global levels. View Full-Text
Keywords: yellow fever virus; flavivirus; vector-borne transmission; emergence yellow fever virus; flavivirus; vector-borne transmission; emergence
Show Figures

Figure 1

MDPI and ACS Style

Klitting, R.; Fischer, C.; Drexler, J.F.; Gould, E.A.; Roiz, D.; Paupy, C.; De Lamballerie, X. What Does the Future Hold for Yellow Fever Virus? (II). Genes 2018, 9, 425.

AMA Style

Klitting R, Fischer C, Drexler JF, Gould EA, Roiz D, Paupy C, De Lamballerie X. What Does the Future Hold for Yellow Fever Virus? (II). Genes. 2018; 9(9):425.

Chicago/Turabian Style

Klitting, Raphaëlle, Carlo Fischer, Jan F. Drexler, Ernest A. Gould, David Roiz, Christophe Paupy, and Xavier De Lamballerie. 2018. "What Does the Future Hold for Yellow Fever Virus? (II)" Genes 9, no. 9: 425.

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

Back to TopTop